We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

172 hedge funds and large institutions have $2B invested in NEVRO CORP. in 2019 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 49 increasing their positions, 49 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

64% more capital invested

Capital invested by funds: $1.22B → $2B (+$779M)

45% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 33

10% more funds holding

Funds holding: 157172 (+15)

0% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 49

14% less call options, than puts

Call options by funds: $25.1M | Put options by funds: $29.1M

Holders
172
Holders Change
+15
Holders Change %
+9.55%
% of All Funds
3.72%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
48
Increased
49
Reduced
49
Closed
33
Calls
$25.1M
Puts
$29.1M
Net Calls
-$3.94M
Net Calls Change
-$17.9M
Name Holding Trade Value Shares
Change
Change in
Stake
MIH
101
Meitav Investment House
Israel
$680K -$376K -8,000 -42%
UBS Group
102
UBS Group
Switzerland
$661K +$298K +6,341 +150%
SCA
103
Secor Capital Advisors
New York
$655K +$60.7K +1,291 +14%
TAM
104
Trillium Asset Management
Massachusetts
$612K +$34.6K +735 +8%
Citigroup
105
Citigroup
New York
$588K +$165K +3,512 +60%
MLICM
106
Metropolitan Life Insurance Company (MetLife)
New York
$580K
PIM
107
Partner Investment Management
California
$575K +$110K +2,338 +34%
BTS
108
BB&T Securities
Virginia
$573K +$432K +9,180 New
OAM
109
Oppenheimer Asset Management
New York
$558K +$283K +6,016 +206%
Barclays
110
Barclays
United Kingdom
$543K +$239K +5,073 +140%
SG Americas Securities
111
SG Americas Securities
New York
$535K -$1.96M -41,609 -83%
Walleye Trading
112
Walleye Trading
New York
$515K +$388K +8,244 New
PC
113
PA Capital
Virginia
$452K +$340K +7,234 New
SO
114
STRS Ohio
Ohio
$433K
BNP Paribas Financial Markets
115
BNP Paribas Financial Markets
France
$419K +$283K +6,028 +901%
Marshall Wace
116
Marshall Wace
United Kingdom
$376K -$941K -20,019 -77%
M&T Bank
117
M&T Bank
New York
$342K +$258K +5,479 New
PI
118
PEAK6 Investments
Illinois
$329K -$629K -13,367 -72%
CCM
119
Copernicus Capital Management
California
$313K +$235K +5,000 New
WA
120
Wealth Architects
California
$313K +$235K +5,000 New
EGM
121
Engineers Gate Manager
New York
$307K -$553K -11,767 -71%
BAM
122
Blueshift Asset Management
New Jersey
$302K +$227K +4,838 New
XK
123
Xact Kapitalforvaltning
Sweden
$297K +$224K +4,758 New
MWNA
124
Marshall Wace North America
New York
$276K +$44.2K +941 +27%
AB
125
Amalgamated Bank
New York
$275K +$207K +4,398 New

NVRO Hedge Fund Activity: Q1 2019 in Review

172 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2019, worth a combined $2B — up 64% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new NVRO positions and 33 closed out — a net gain of 15 holders — while 49 added to existing stakes and 49 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $29.2M. The largest seller was Point72 Asset Management, cutting an estimated $50.9M.

  • 172 institutional investors held NEVRO CORP. (NVRO) as of Q1 2019, up from 157 in Q4 2018.
  • Funds reported $2B of NEVRO CORP. stock for Q1 2019, up 64% quarter-over-quarter.
  • 48 funds opened new NEVRO CORP. positions in Q1 2019 and 33 closed out, a net change of +15 holders.
  • The largest NEVRO CORP. buyer in Q1 2019 was T. Rowe Price Associates, an estimated $29.2M added.
  • The largest NEVRO CORP. seller in Q1 2019 was Point72 Asset Management, an estimated $50.9M sold.

Based on aggregated 13F filings for Q1 2019.